216 related articles for article (PubMed ID: 20430735)
1. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
Czyzewska J; Guzinska-Ustymowicz K; Kemona A
Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection and expressions of EGF, EGFR and c-erbB-2 proteins in gastric carcinoma.
Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
Folia Histochem Cytobiol; 2009 Jan; 47(3):447-51. PubMed ID: 20164030
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factors and apoptosis markers in pancreatic ductal adenocarcinoma.
Pryczynicz A; Guzińska-Ustymowicz K; Czyzewska J; Kemona A
Folia Histochem Cytobiol; 2009; 47(4):667-71. PubMed ID: 20430737
[TBL] [Abstract][Full Text] [Related]
4. Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.
Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
Anticancer Res; 2008; 28(2B):1399-404. PubMed ID: 18505086
[TBL] [Abstract][Full Text] [Related]
5. The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival.
Czyzewska J; Guzińska-Ustymowicz K; Kemona A; Bandurski R
Folia Histochem Cytobiol; 2008; 46(1):57-64. PubMed ID: 18296264
[TBL] [Abstract][Full Text] [Related]
6. The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis.
Czyzewska J; Guzińska-Ustymowicz K; Ustymowicz M; Pryczynicz A; Kemona A
Folia Histochem Cytobiol; 2010 Jan; 48(1):37-45. PubMed ID: 20529814
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of EGF, c-erbB-2 and EGFR in intestinal variant of gastric adenocarcinomas.
Docea AO; Mitruţ P; Cernea D; Georgescu CC; Olimid D; Mărgăritescu C; Dumitrescu D
Rom J Morphol Embryol; 2013; 54(3):545-54. PubMed ID: 24068402
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.
Czyzewska J; Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Bandurski R
Folia Histochem Cytobiol; 2009; 47(2):289-96. PubMed ID: 19995716
[TBL] [Abstract][Full Text] [Related]
9. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.
Tokunaga A; Onda M; Okuda T; Teramoto T; Fujita I; Mizutani T; Kiyama T; Yoshiyuki T; Nishi K; Matsukura N
Cancer; 1995 Mar; 75(6 Suppl):1418-25. PubMed ID: 7889468
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
[TBL] [Abstract][Full Text] [Related]
12. Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas.
Saeki T; Salomon DS; Johnson GR; Gullick WJ; Mandai K; Yamagami K; Moriwaki S; Tanada M; Takashima S; Tahara E
Jpn J Clin Oncol; 1995 Dec; 25(6):240-9. PubMed ID: 8523820
[TBL] [Abstract][Full Text] [Related]
13. The impact of Helicobacter pylori on EGF, EGF receptor, and the c-erb-B2 expression.
Jurkowska G; Piotrowska-Staworko G; Guzińska-Ustymowicz K; Kemona A; Świdnicka-Siergiejko A; Łaszewicz W; Dąbrowski A
Adv Med Sci; 2014 Sep; 59(2):221-6. PubMed ID: 25051417
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor in gastric carcinoma as a risk factor of postoperative recurrence.
Ichiyoshi Y; Tateishi M; Toda T; Minamizono Y; Nagasaki S; Yao T; Sugimachi K
Int Surg; 1993; 78(3):196-9. PubMed ID: 8276539
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
[TBL] [Abstract][Full Text] [Related]
16. c-erbB-2 expression is predictive for lymphatic spread of clinical gastric carcinoma.
Orita H; Maehara Y; Emi Y; Kakeji Y; Baba H; Korenaga D; Sugimachi K
Hepatogastroenterology; 1997; 44(13):294-8. PubMed ID: 9058162
[TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
18. Decreased HCRP1 expression is associated with poor prognosis in breast cancer patients.
Xu J; Yang W; Wang Q; Zhang Q; Li X; Lin X; Liu X; Qin Y
Int J Clin Exp Pathol; 2014; 7(11):7915-22. PubMed ID: 25550832
[TBL] [Abstract][Full Text] [Related]
19. Distribution of prognostically unfavourable product of c-erbB-2 oncogene and EGF-R in carcinomas of the breast and uterine cervix.
Ray A; Naik SL; Sharma BK
Indian J Physiol Pharmacol; 2002 Oct; 46(4):423-33. PubMed ID: 12683217
[TBL] [Abstract][Full Text] [Related]
20. Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer.
Byeon SJ; Lee HS; Kim MA; Lee BL; Kim WH
Pathobiology; 2017; 84(4):210-217. PubMed ID: 28399526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
